immunological platform (Inserm Transfert)
90
Structured Review
Inserm Transfert
immunological platform
Immunological Platform, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/immunological+platform/immunological+platform/pm23252690-189-52-29
Average 90 stars, based on 1 article reviews
Immunological Platform, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/immunological+platform/immunological+platform/pm23252690-189-52-29
Average 90 stars, based on 1 article reviews
immunological platform - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Biomarker Discovery:Article Title: Donor selection and release criteria of cellular therapy products. Article Snippet: Within the last two decades, an increasing number of transfusion services worldwide significantly expanded their activities on the development and production of cellular therapy (CT) products, including the provision of cellular therapeutics for their use in clinical trials [1].. Due to the increasing importance of CT for Transfusion Medicine, the Editorial Board of Vox Sanguinis decided in 2007 to establish the new section ‘Cellular Therapy’ as the fifth section of the journal [2].. Within the first 5 years, a yearly increasing number of manuscripts have been submitted for publication. Activity Assay:Article Title: Donor selection and release criteria of cellular therapy products. Article Snippet: Within the last two decades, an increasing number of transfusion services worldwide significantly expanded their activities on the development and production of cellular therapy (CT) products, including the provision of cellular therapeutics for their use in clinical trials [1].. Due to the increasing importance of CT for Transfusion Medicine, the Editorial Board of Vox Sanguinis decided in 2007 to establish the new section ‘Cellular Therapy’ as the fifth section of the journal [2].. Within the first 5 years, a yearly increasing number of manuscripts have been submitted for publication. |